Cargando…
Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma
BACKGROUND: Different theories have been postulated to explain the development of nodular prostatic hyperplasia (NPH). Epithelial to mesenchymal transition (EMT) is a physiologic process in which the epithelial cells lose their polarity and cell-cell adhesion and acquire a mesenchymal phenotype. AIM...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442322/ https://www.ncbi.nlm.nih.gov/pubmed/31008053 http://dx.doi.org/10.4103/JMAU.JMAU_46_18 |
_version_ | 1783407693278478336 |
---|---|
author | Abdallah, Rania Abdallah Abdou, Asmaa Gaber Abdelwahed, Moshira Ali, Hend |
author_facet | Abdallah, Rania Abdallah Abdou, Asmaa Gaber Abdelwahed, Moshira Ali, Hend |
author_sort | Abdallah, Rania Abdallah |
collection | PubMed |
description | BACKGROUND: Different theories have been postulated to explain the development of nodular prostatic hyperplasia (NPH). Epithelial to mesenchymal transition (EMT) is a physiologic process in which the epithelial cells lose their polarity and cell-cell adhesion and acquire a mesenchymal phenotype. AIM: The aim of the present study is to investigate the potential role of E- and N-cadherin in the induction of EMT in NPH and prostatic carcinoma. METHODS: This study was carried out on 55 cases of NPH and 20 cases prostatic carcinoma for evaluation of immunohistochemical expression of E and N cadherins. RESULTS: Most NPH (54/55 cases, 98.2%) and all cases of prostatic carcinoma showed positive N-cadherin expression in prostatic glands and stroma. High percentage of N-cadherin expression by stromal cells was significantly in favor of prostatic carcinoma compared to NPH. High percentage of N-cadherin expression by epithelial cells of carcinoma group was significantly associated with young age while its high expression by stromal cells was significantly associated with multicentricity. About 96.4% of NPH and 75% of prostatic carcinoma showed positive E-cadherin expression with a significant difference. No significant association between E-cadherin and N-cadherins in both NPH and prostatic carcinoma was identified. CONCLUSIONS: The prominent expression of N-cadherin in large numbers of NPH and prostate carcinoma cases in the epithelial and stromal components could point to the occurrence of EMT in those diseases. It also opens a new gate for treatment of those patients by targeting N-cadherin molecule. The absence of inverse association between E-cadherin and N-cadherins in NPH and prostatic carcinoma may indicate that cadherin switch is not an essential step for the development of EMT. |
format | Online Article Text |
id | pubmed-6442322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-64423222019-04-19 Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma Abdallah, Rania Abdallah Abdou, Asmaa Gaber Abdelwahed, Moshira Ali, Hend J Microsc Ultrastruct Original Article BACKGROUND: Different theories have been postulated to explain the development of nodular prostatic hyperplasia (NPH). Epithelial to mesenchymal transition (EMT) is a physiologic process in which the epithelial cells lose their polarity and cell-cell adhesion and acquire a mesenchymal phenotype. AIM: The aim of the present study is to investigate the potential role of E- and N-cadherin in the induction of EMT in NPH and prostatic carcinoma. METHODS: This study was carried out on 55 cases of NPH and 20 cases prostatic carcinoma for evaluation of immunohistochemical expression of E and N cadherins. RESULTS: Most NPH (54/55 cases, 98.2%) and all cases of prostatic carcinoma showed positive N-cadherin expression in prostatic glands and stroma. High percentage of N-cadherin expression by stromal cells was significantly in favor of prostatic carcinoma compared to NPH. High percentage of N-cadherin expression by epithelial cells of carcinoma group was significantly associated with young age while its high expression by stromal cells was significantly associated with multicentricity. About 96.4% of NPH and 75% of prostatic carcinoma showed positive E-cadherin expression with a significant difference. No significant association between E-cadherin and N-cadherins in both NPH and prostatic carcinoma was identified. CONCLUSIONS: The prominent expression of N-cadherin in large numbers of NPH and prostate carcinoma cases in the epithelial and stromal components could point to the occurrence of EMT in those diseases. It also opens a new gate for treatment of those patients by targeting N-cadherin molecule. The absence of inverse association between E-cadherin and N-cadherins in NPH and prostatic carcinoma may indicate that cadherin switch is not an essential step for the development of EMT. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6442322/ /pubmed/31008053 http://dx.doi.org/10.4103/JMAU.JMAU_46_18 Text en Copyright: © 2019 Journal of Microscopy and Ultrastructure http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Abdallah, Rania Abdallah Abdou, Asmaa Gaber Abdelwahed, Moshira Ali, Hend Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma |
title | Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma |
title_full | Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma |
title_fullStr | Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma |
title_full_unstemmed | Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma |
title_short | Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma |
title_sort | immunohistochemical expression of e- and n-cadherin in nodular prostatic hyperplasia and prostatic carcinoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442322/ https://www.ncbi.nlm.nih.gov/pubmed/31008053 http://dx.doi.org/10.4103/JMAU.JMAU_46_18 |
work_keys_str_mv | AT abdallahraniaabdallah immunohistochemicalexpressionofeandncadherininnodularprostatichyperplasiaandprostaticcarcinoma AT abdouasmaagaber immunohistochemicalexpressionofeandncadherininnodularprostatichyperplasiaandprostaticcarcinoma AT abdelwahedmoshira immunohistochemicalexpressionofeandncadherininnodularprostatichyperplasiaandprostaticcarcinoma AT alihend immunohistochemicalexpressionofeandncadherininnodularprostatichyperplasiaandprostaticcarcinoma |